Hospital Universitário de Brasília, Serviço de Dermatologia, Brasília, DF, Brasil.
Universidade de Brasília, Faculdade de Medicina, Pós-graduação em Ciências Médicas, Brasília, DF, Brasil.
Rev Soc Bras Med Trop. 2020 Nov 6;53:e20200504. doi: 10.1590/0037-8682-0504-2020. eCollection 2020.
Coronavirus disease 2019 (COVID-19) was first officially described in Brazil on February 26th, 2020. The accumulation of reports of concomitant infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and pathogens that cause diseases endemic to tropical countries, such as dengue and chikungunya fever, has started to draw attention. Chagas disease and leprosy remain public health problems in many developing countries, such as Brazil. In this manuscript, we describe a case of concomitant leprosy, Chagas disease, and COVID-19, highlighting the cutaneous manifestations of SARS-CoV-2 infection and the clinical behavior of household contacts who previously received prophylactic Bacillus Calmette-Guérin vaccines.
2020 年 2 月 26 日,巴西首次正式描述了 2019 年冠状病毒病(COVID-19)。越来越多的报告显示,严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)与导致热带国家地方性疾病(如登革热和基孔肯雅热)的病原体同时感染,开始引起关注。恰加斯病和麻风病仍然是巴西等许多发展中国家的公共卫生问题。在本文中,我们描述了一例同时患有麻风病、恰加斯病和 COVID-19 的病例,重点介绍了 SARS-CoV-2 感染的皮肤表现以及先前接受卡介苗预防性疫苗接种的家庭接触者的临床行为。